证券代码：601117 股票简称：中国化学 公告编号：临 2024-039 中国化学工程股份有限公司 关于控股股东一致行动人增持公司股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 重要内容提示： 增持计划基本情况：中国化学工程股份有限公司（以下简 称"公司"）于 2024 年 2 月 20 日在上海证券交易所网站披露了 《中国化学工程股份有限公司关于控股股东一致行动人增持公 司股份计划的公告》（公告编号：临 2024-006），公司控股股东 中国化学工程集团有限公司（以下简称"中国化学工程"）的一 致行动人国化投资集团有限公司（以下简称"国化公司"） 拟自 该公告披露之日起 12 个月内通过上海证券交易所系统允许的方 式增持公司 A 股股份，增持总金额不低于人民币 2 亿元，不超过 人民币 4 亿元（以下简称"增持计划"）。 增持进展情况：国化公司于 2024 年 3 月 16 日至 2024 年 8 月 13 日期间通过上海证券交易所交易系统以集中竞价交易方式 增持公司13,045,900股A股股份， ...

Investment Rating - The report maintains a "Buy" rating for the company [3]. Core Insights - The successful breakthrough of the adiponitrile project is expected to accelerate the domestic development of nylon 66, which has been historically dominated by foreign technology [1][18]. - The supply structure shows that the top three global producers account for over 80% of the market, with significant domestic capacity planned but uncertain release schedules [19][20]. - Demand analysis indicates that the acceleration of adiponitrile localization and cost reductions will broaden the applications of PA66, particularly in automotive lightweighting and synthetic fibers [22][28]. Summary by Sections 1. Adiponitrile Project Breakthrough - The adiponitrile project has successfully overcome key technological barriers, enabling the domestic production of nylon 66, which is widely used in various industries [1][18]. - The project is part of a larger initiative to establish a nylon 66 new materials base in Shandong, with an initial capacity of 200,000 tons [1][18]. 2. Supply Structure - As of the end of 2023, global adiponitrile production capacity is concentrated among six companies, with a total capacity of 2.36 million tons, where major players like Invista, BASF, and Ascend account for over 80% [19][20]. - Domestic production is ramping up, with 400,000 tons planned, but the actual release of this capacity may face technical challenges [19][20]. 3. Demand Analysis - The overall consumption of nylon 66 in China is stable, with 650,000 tons expected in 2023, reflecting a 20% year-on-year increase due to the acceleration of adiponitrile localization [22][26]. - The automotive sector is a significant driver for nylon 66, with its lightweight properties making it a suitable alternative to traditional metals, especially as the penetration of new energy vehicles increases [28][31]. 4. Progress of the Company’s Adiponitrile Project - The company’s adiponitrile project is progressing well, currently operating at 45% capacity, with plans for further expansion [1][4]. - The project is expected to contribute significant profits upon reaching full capacity, with estimated profits of 690 million and 1.72 billion yuan for the first and second phases, respectively [1][4]. 5. Investment Recommendations - The company is currently trading at a historical low valuation, with a PE ratio of 7.93 and a PB ratio of 0.76, indicating potential for price appreciation [1][3]. - Forecasted net profits for 2024-2026 are expected to grow by 10%, 15%, and 17%, respectively, suggesting a positive outlook for the company’s financial performance [1][2].

中国化学工程股份有限公司（以下简称"公司"）监事会于 近日收到职工监事朱今风先生的书面辞职报告，因工作调整原因， 朱今风先生申请辞去公司第五届监事会职工监事职务，辞职后其 仍将在公司担任其他职务。 证券代码：601117 股票简称：中国化学 公告编号：临 2024-036 中国化学工程股份有限公司 关于职工监事辞职暨补选职工监事的公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 一、职工监事辞职情况 朱今风先生在担任公司职工监事期间恪尽职守、勤勉尽责， 为公司规范运作和健康发展发挥了重要作用，公司及公司监事会 对朱今风先生在任职期间所作出的贡献表示衷心感谢！ 根据《公司法》《公司章程》等规定，朱今风先生辞去职工 监事职务将导致公司监事会人数低于法定最低人数、职工代表监 事比例低于三分之一，故其辞职申请将在补选出新任职工监事后 生效。在辞职申请生效前，朱今风先生仍按照相关法律法规和《公 司章程》的规定，履行了公司职工监事职责。 二、补选职工监事情况 1 2 赖中茂先生简历 为保证公司监事会正常运作，根据《公司法》《公 ...

证券代码：601117 股票简称：中国化学 公告编号：临 2024-035 中国化学工程股份有限公司 关于经营情况简报的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 现将公司 2024 年 1-6 月主要经营情况公布如下，供各位投 资者参阅。 | | | | 业务类型 | 数量 | 合同金额 | | --- | --- | --- | | 建筑工程承包 | 1718 | 1944.34 | | 化学工程 其 | 1365 | 1502.87 | | 基础设施 中 | 281 | 351.37 | | 环境治理 | 72 | 90.10 | | 勘察设计监理咨询 | 1031 | 21.05 | | 实业及新材料销售 | | 41.90 | | 现代服务业 | | 5.90 | | 其他 | | 22.50 | | 合计 | 2749 | 2035.69 | 单位：亿元 币种：人民币 1 二、 按地区分布统计 单位：亿元 币种：人民币 | 地区 | 合同金额 | | --- | --- | | 境内 | 1622 ...

Investment Rating - The report maintains a "Recommended" rating for the company [2][3]. Core Views - The company has a solid cash position, with a dividend payout ratio of 20.04% based on a net profit of 5.426 billion yuan in 2023, indicating potential for significant increases in dividends in the future [2]. - The company experienced an 18.11% year-on-year increase in total contract value from January to May 2024, with overseas contracts growing by 410% [2]. - The company is focusing on innovation-driven development in high-performance fibers, high-end nylon new materials, and biodegradable plastics, with significant advancements in domestic production technology [2]. - The projected net profits for 2024-2026 are 6.216 billion yuan, 6.991 billion yuan, and 7.815 billion yuan respectively, with corresponding PE ratios of 8X, 7X, and 6X [2]. Financial Forecasts - Revenue for 2023 is projected at 179.196 billion yuan, with a growth rate of 13.1%, and expected to reach 209.542 billion yuan in 2024, reflecting a growth rate of 16.9% [3][7]. - The net profit attributable to shareholders is forecasted to be 5.426 billion yuan in 2023, increasing to 6.216 billion yuan in 2024, representing a growth rate of 14.6% [3][7]. - The company’s earnings per share (EPS) is expected to rise from 0.89 yuan in 2023 to 1.02 yuan in 2024 [3][7].

证券代码：601117 证券简称：中国化学 公告编号：2024-034 中国化学工程股份有限公司 2023 年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示： 差异化分红送转： 否 一、通过分配方案的股东大会届次和日期 本次利润分配方案经公司 2024 年 5 月 20 日的 2023 年年度股 东大会审议通过。 二、分配方案 1.发放年度：2023 年年度 2.分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登 记结算有限责任公司上海分公司（以下简称"中国结算上海分公 司"）登记在册的本公司全体股东。 每股分配比例 A 股每股现金红利 0.178 元（含税） 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2024/7/12 | － | 2024/7/15 | 2024/7/15 | 3.分配方案： 三、相关日期 本次利润分配以实施回购注销 202 ...

第五届董事会第十八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 重要内容提示： 一、董事会会议召开情况 中国化学工程股份有限公司（以下简称"公司"）第五届董 事会第十八次会议通知于 2024 年 6 月 21 日以书面直接送达和电 子邮件等方式发出，会议于 2024 年 6 月 28 日以通讯会议的方式 召开。本次会议应出席董事 6 人，实际出席董事 6 人。会议由董 事长莫鼎革先生主持。本次会议的召开符合有关法律、行政法规、 规范性文件和公司章程、董事会议事规则的相关规定。 二、董事会会议审议情况 （一）审议通过《关于聘任公司副总经理的议案》； 证券代码：601117 股票简称：中国化学 公告编号：临 2024-033 中国化学工程股份有限公司 本议案已经董事会提名委员会审议通过。 特此公告。 中国化学工程股份有限公司 二○二四年六月二十八日 2 邓兆敬先生简历 邓兆敬，男，1970 年 9 月出生，中共党员，硕士研究生， 正高级工程师，享受国务院政府特殊津贴专家。现任中国化学工 程集团有限公司党委 ...

证券代码：601117 股票简称：中国化学 公告编号：临 2024-032 中国化学工程股份有限公司 关于 2022 年限制性股票激励计划部分限制性股票 回购注销实施的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 重要内容提示： 回购注销原因：根据中国化学工程股份有限公司（以下简 称"公司"）《2022 年限制性股票激励计划（草案）》（以下简称 "《激励计划》"）、《2022 年限制性股票激励管理办法》《2022 年 限制性股票激励实施考核管理办法》等相关规定，公司本次回购 注销 2 名激励对象因个人原因主动离职、1 名激励对象因工作调 动已获授但尚未解除限售的限制性股票共计 40.00 万股。本次注 销完成后， 公 司 总 股 本 将 由 6,109,470,562 股变更为 6,109,070,562 股。 本次注销股份的有关情况： 单位：股 | 回购股份数量（股） | 注销股份数量（股） | 注销日期 | | | | | | --- | --- | --- | --- | --- | --- | --- ...

Investment Rating - The report maintains a "Buy" rating for the company [5] Core Views - The company has shown resilient growth in new contract signings, with a total of 167.4 billion yuan in new contracts from January to May 2024, representing an 18.1% year-on-year increase [2] - The company is actively expanding into strategic emerging industries, including new materials and high-end equipment manufacturing, while achieving significant operational load increases in its industrial business [3] - The company is expected to maintain strong profit growth, with projected net profits of 58.9 billion yuan, 64.2 billion yuan, and 71.2 billion yuan for 2024, 2025, and 2026 respectively [3] Summary by Sections New Contract Signings - From January to May 2024, the company signed new contracts worth 167.4 billion yuan, up 18.1% year-on-year, with significant contributions from chemical engineering contracts [2] - Domestic new contracts decreased by 2.8% year-on-year, while overseas contracts surged by 410% [2] Industrial Business Performance - As of May 2024, the company's industrial projects are operating at 45% capacity for the adiponitrile project and 83% for the aerogel project [3] - The company is focusing on overcoming key technological challenges and has made advancements in the production of high-performance nylon materials [3] Financial Projections - The company forecasts revenue growth from 195.9 billion yuan in 2024 to 231.8 billion yuan in 2026, with a net profit growth rate of 8.5% in 2024 [4] - The report highlights a stable P/E ratio of 8 for the forecasted years, indicating a favorable valuation [4]

Investment Rating - The report maintains a "Buy" rating for the company [5] Core Views - The company has shown resilient growth in new contract signings, with a total of 167.4 billion yuan in new contracts from January to May 2024, representing an 18.1% year-on-year increase [2] - The company is actively expanding its presence in strategic emerging industries, including new materials and high-end equipment manufacturing, while achieving significant operational load increases in its industrial projects [3] - The company is expected to maintain strong profit growth, with projected net profits of 58.9 billion yuan, 64.2 billion yuan, and 71.2 billion yuan for 2024, 2025, and 2026 respectively [3] Summary by Sections New Contract Signings - From January to May 2024, the company signed new contracts worth 167.4 billion yuan, up 18.1% year-on-year, with significant contributions from chemical engineering contracts [2] - Domestic new contracts decreased by 2.8% to 130.8 billion yuan, while overseas contracts surged by 410% to 36.7 billion yuan during the same period [2] Business Operations - The company's industrial business load has been increasing, with the butadiene project operating at 45% capacity and the aerogel project at 83% capacity as of May 2024 [3] - The company is focusing on overcoming key technological challenges and has made advancements in the production of high-performance nylon materials and photovoltaic cell raw materials [3] Financial Projections - The company’s revenue is projected to grow from 178.4 billion yuan in 2023 to 195.9 billion yuan in 2024, with a revenue growth rate of 9.81% [4] - Net profit is expected to increase from 5.4 billion yuan in 2023 to 5.9 billion yuan in 2024, reflecting an 8.5% growth rate [4]